Get started
Author

Claire K. Mulvey

Observed names: C. Mulvey, Claire K Mulvey, Claire Mulvey, Mulvey Claire, Mulvey Claire K.
Observed institutions: Thomas Jefferson University, University of California, San Francisco, University of California San Francisco Medical Center, Cardiovascular Institute of Philadelphia, UCSF Helen Diller Family Comprehensive Cancer Center, The Ohio State University, University of Pennsylvania
ORCID: 0000-0002-7880-8507
Observed ORCID: 0000-0002-7880-8507
OpenAlex ID: A5027172182
Race and gender variation in response to evoked inflammation
2013 · Jane F Ferguson, Parth N Patel, et al. · Journal of Translational Medicine · 105
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: A Phase II Multicenter Study
2024 · Collin M. Blakely, Anatoly Urisman, et al. · Journal of Clinical Oncology · 72
Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides
2014 · Stuart B. Prenner, Claire K. Mulvey, et al. · Atherosclerosis · 55
Omega‐3 PUFA supplementation and the response to evoked endotoxemia in healthy volunteers
2013 · Jane F. Ferguson, Claire K. Mulvey, et al. · Molecular Nutrition & Food Research · 48
Periprocedural Management of Patients Undergoing Liver Resection or Embolotherapy for Neuroendocrine Tumor Metastases
2019 · Daniel H. Kwon, Alan Paciorek, et al. · Pancreas · 33
Ascending and descending thoracic aorta calcification in type 2 diabetes mellitus
2015 · Timothy W. Churchill, Suraj P. Rasania, et al. · Journal of cardiovascular computed tomography · 31
Non-compressible arterial disease and the risk of coronary calcification in type-2 diabetes
2013 · Scott M. Lilly, Atif N. Qasim, et al. · Atherosclerosis · 27
Phase II study of pembrolizumab-based therapy in previously treated extrapulmonary poorly differentiated neuroendocrine carcinomas: Results of Part A (pembrolizumab alone).
2019 · Claire Mulvey, Nitya Prabhakar Raj, et al. · Journal of Clinical Oncology · 24
Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR-mutated non-small cell lung cancer.
2023 · Jacqueline V. Aredo, Anatoly Urisman, et al. · Journal of Clinical Oncology · 23
Cardiovascular risk factors and mitral annular calcification in type 2 diabetes
2012 · Atif N. Qasim, Hashmi Rafeek, et al. · Atherosclerosis · 22
Differential Associations of Oral Glucose Tolerance Test–Derived Measures of Insulin Sensitivity and Pancreatic β-Cell Function With Coronary Artery Calcification and Microalbuminuria in Type 2 Diabetes
2013 · Claire K. Mulvey, Ann M. McNeill, et al. · Diabetes Care · 18
PDF
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas
2023 · Nitya Raj, Jennifer A. Chan, et al. · British Journal of Cancer · 14
PDF
Checkpoint Inhibitor Immunotherapy to Treat Temozolomide-Associated Hypermutation in Advanced Atypical Carcinoid Tumor of the Lung
2022 · Fangdi Sun, James P. Grenert, et al. · JCO Precision Oncology · 14
Peroxisome Proliferator–Activated Receptor‐α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia
2012 · Claire K. Mulvey, Jane F. Ferguson, et al. · Journal of the American Heart Association · 13
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancer
2024 · Howard J Lee, John Boscardin, et al. · The Oncologist · 9
Osimertinib-induced biventricular cardiomyopathy with abnormal cardiac MRI findings: a case report
2023 · Karishma Patel, Kristie Y. Hsu, et al. · Cardio-Oncology · 8
PDF
Systemic Therapies for Advanced Gastrointestinal Carcinoid Tumors
2015 · Claire K. Mulvey, Emily K. Bergsland · Hematology/Oncology Clinics of North America · 8
A phase I/Ib study of the aurora kinase A inhibitor alisertib in combination with osimertinib in advanced osimertinib-resistant EGFR-mutated lung cancer.
2024 · Turja Chakrabarti, Greg M. Allen, et al. · Journal of Clinical Oncology · 7
Selective association of electrocardiographic abnormalities with insulin sensitivity and beta‐cell function in type 2 diabetes mellitus: a cross‐sectional analysis
2016 · Anish B. Bhatt, Claire K. Mulvey, et al. · Diabetes/Metabolism Research and Reviews · 7
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026
2026 · Apar Kishor P. Ganti, Billy W. Loo, et al. · Journal of the National Comprehensive Cancer Network · 6
Complicated Case Presentation
2017 · Claire K. Mulvey, Katherine Van Loon, et al. · Pancreas · 6
Burdens of Gastroenteropancreatic Neuroendocrine Neoplasm by Diverse Race and Ethnicities— A Rigorous Structural Equation Modeling
2025 · Alan Paciorek, Claire Mulvey, et al. · Journal of the National Comprehensive Cancer Network · 4
Emerging Precision Medicine Approaches for Lung Neuroendocrine Tumors
2023 · Claire K. Mulvey · Cancers · 4
PDF
Survival outcomes for lung neuroendocrine tumors in California differ by sociodemographic factors
2023 · Claire K Mulvey, Alan Paciorek, et al. · Endocrine Related Cancer · 4
PDF
OA13.03 RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor-Expressing Extensive-Stage SCLC
2025 · A.S. Mansfield, E. Parent, et al. · Journal of Thoracic Oncology · 1
Works count: 59
Citation count: 566
H-index: 13
I10-index: 14
Year
Topic
Type